Methodology

Coulter DM. The development of Prescription Event Monitoring in the New Zealand Intensive Medicines Monitoring Programme. In: Mann R and Andrews, editors. Pharmacovigilance. Chichester: John Wiley & Sons Ltd 2002. p. 345-62 

Coulter DM. Signal generation in the New Zealand Intensive Medicines Monitoring Programme: a combined clinical and statistical approach. Drug Safety 2002;25(6):433-9 

Coulter DM. Privacy issues and the monitoring of sumatriptan in the New Zealand Intensive Medicines Monitoring Programme. Pharmacoepodemiology and Drug Safety 2001;10:1-5. 

Coulter DM. The New Zealand Intensive Medicines Monitoring Programme in pro-active safety surveillance. Pharmacoepidemiology and Drug Safety 2000;9:273-280 

Clark D, Morgan A, Hananeia L, Coulter D and Olds R. Drug Metabolism Genotypes and their association with adverse reactions in selected populations: a pilot study of methodology. Pharmacoepidemiology and Drug Safety 2000;9:393-400